Kinarus Therapeutics AG

Swiss Biotech Association

Member

Kinarus AG is a clinical-stage pharmaceutical company focused on bringing novel treatments to patients suffering from viral, respiratory, and ophthalmic diseases. Kinarus’s unique and innovative combinatorial therapeutic candidate has broad potential to transform numerous therapeutic areas.

Facts & figures

Type of organization

Public company
Year of foundation

2017
Number of employees in Switzerland

1-9

Key business

Core competencies

Products

You may also be interested in

Solvias AG

Solvias is a contract research, development & manufacturing
We offer early phase development of small molecules API by process R&D and GMP-manufacturing integrated with high through-put screening, solid state and a wide ligand portfolios for catalytic transformations and analytical services.
Kaiseraugst

Member

Porton Pharmaceutical Chemicals GmbH

Porton Pharma is a a leading CDMO with operations and commercial offices across the US, EU and China. Porton Pharma provides global pharmaceutical companies with innovative, reliable and end-to-end process R&D and manufacturing services across small molecules, dosage forms and biologics.
6039 Root

Member

Bavarian Nordic Berna GmbH

Bavarian Nordic is a fully integrated vaccine company focused on the development, manufacturing and commercialization of life-saving vaccines. Our manufacturing site for oral vaccines is located in Thörishaus, 15 km southwest of Bern.
3174 Thörishaus

Member